Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × Recurrence × Panobinostat × Clear all

Status

Completed 7 Terminated 4 Withdrawn 1 No longer available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 2 Recurrence 1

Interventions

zanubrutinib 1 sugemalimab 1 revumenib 1 loncastuximab tesirine 1 fludarabine phosphate 1 denileukin diftitox 1 Whole-Body Irradiation 1 Tacrolimus 1 Panobinostat 1 Mycophenolic Acid 1 Cytarabine 1 Cord Blood Stem Cell Transplantation 1 Busulfan 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02568943 2020-04-08

An Expanded Treatment Protocol of Panobinostat in Combination Therapy for Relapsed, and Relapsed and Refractory Multiple Myeloma

Novartis

No longer available

Multiple Myeloma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡